Literature DB >> 23448871

Postsynaptic NO/cGMP increases NMDA receptor currents via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.

Angela Neitz1, Evanthia Mergia2, Barbara Imbrosci1, Elisabeth Petrasch-Parwez3, Ulf T Eysel4, Doris Koesling2, Thomas Mittmann1.   

Abstract

The nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) signaling cascade participates in the modulation of synaptic transmission. The effects of NO are mediated by the NO-sensitive cGMP-forming guanylyl cyclases (NO-GCs), which exist in 2 isoforms with indistinguishable regulatory properties. The lack of long-term potentiation (LTP) in knock-out (KO) mice deficient in either one of the NO-GC isoforms indicates the contribution of both NO-GCs to LTP. Recently, we showed that the NO-GC1 isoform is located presynaptically in glutamatergic neurons and increases the glutamate release via hyperpolarization-activated cyclic nucleotide (HCN)-gated channels in the hippocampus. Electrophysiological analysis of hippocampal CA1 neurons in whole-cell recordings revealed a reduction of HCN currents and a hyperpolarizing shift of the activation curve in the NO-GC2 KOs associated with reduced resting membrane potentials. These features were mimicked in wild-type (WT) neurons with an NO-GC inhibitor. Analysis of glutamate receptors revealed a cGMP-dependent reduction of NMDA receptor currents in the NO-GC2 KO mice, which was mimicked in WT by HCN channel inhibition. Lowering extracellular Mg(2+) increased NMDA receptor currents in the NO-GC2 KO and allowed the induction of LTP that was absent at physiological Mg(2+). In sum, our data indicate that postsynaptic cGMP increases the N-methyl-D-aspartate (NMDA) receptor current by gating HCN channels and thereby is required for LTP.
© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HCN channels; KO; NMDA receptor; NO; cGMP; guanylyl cyclase; hippocampus

Mesh:

Substances:

Year:  2013        PMID: 23448871     DOI: 10.1093/cercor/bht048

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  17 in total

1.  NO regulates the strength of synaptic inputs onto hippocampal CA1 neurons via NO-GC1/cGMP signalling.

Authors:  A Neitz; E Mergia; U Neubacher; D Koesling; T Mittmann
Journal:  Pflugers Arch       Date:  2014-07-11       Impact factor: 3.657

2.  Cannabinoid Control of Learning and Memory through HCN Channels.

Authors:  Mattia Maroso; Gergely G Szabo; Hannah K Kim; Allyson Alexander; Anh D Bui; Sang-Hun Lee; Beat Lutz; Ivan Soltesz
Journal:  Neuron       Date:  2016-02-18       Impact factor: 17.173

3.  Prohibitin S-Nitrosylation Is Required for the Neuroprotective Effect of Nitric Oxide in Neuronal Cultures.

Authors:  Youyang Qu; Csaba Konrad; Corey Anderson; Liping Qian; Tina Yin; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  J Neurosci       Date:  2020-03-09       Impact factor: 6.167

4.  Hyperpolarization-activated, cyclic nucleotide-gated cation channels in Aplysia: Contribution to classical conditioning.

Authors:  Qizong Yang; Pavlo Kuzyk; Igor Antonov; Caleb J Bostwick; Andrea B Kohn; Leonid L Moroz; Robert D Hawkins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

5.  Nitric oxide selectively suppresses IH currents mediated by HCN1-containing channels.

Authors:  Cornelia Kopp-Scheinpflug; Beatrice M Pigott; Ian D Forsythe
Journal:  J Physiol       Date:  2015-02-19       Impact factor: 5.182

6.  BDNF-induced nitric oxide signals in cultured rat hippocampal neurons: time course, mechanism of generation, and effect on neurotrophin secretion.

Authors:  Richard Kolarow; Christoph R W Kuhlmann; Thomas Munsch; Christoph Zehendner; Tanja Brigadski; Heiko J Luhmann; Volkmar Lessmann
Journal:  Front Cell Neurosci       Date:  2014-11-07       Impact factor: 5.505

7.  Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.

Authors:  Jia Luo; Sue H Lee; Lawren VandeVrede; Zhihui Qin; Sujeewa Piyankarage; Ehsan Tavassoli; Rezene T Asghodom; Manel Ben Aissa; Mauro Fà; Ottavio Arancio; Lan Yue; David R Pepperberg; Gregory R J Thatcher
Journal:  BMC Neurosci       Date:  2015-10-19       Impact factor: 3.288

8.  Suppressive effect of exogenous carbon monoxide on endotoxin-stimulated platelet over-activation via the glycoprotein-mediated PI3K-Akt-GSK3β pathway.

Authors:  Dadong Liu; Xu Wang; Weiting Qin; Jingjia Chen; Yawei Wang; Mingfeng Zhuang; Bingwei Sun
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379

9.  A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.

Authors:  Jia Luo; Sue H Lee; Lawren VandeVrede; Zhihui Qin; Manel Ben Aissa; John Larson; Andrew F Teich; Ottavio Arancio; Yohan D'Souza; Ahmed Elharram; Kevin Koster; Leon M Tai; Mary Jo LaDu; Brian M Bennett; Gregory R J Thatcher
Journal:  Mol Neurodegener       Date:  2016-04-29       Impact factor: 14.195

Review 10.  Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension.

Authors:  Evanthia Mergia; Johannes Stegbauer
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.